Alongside biosimilars, Beneva has forged product listing agreements that offer a 12% average discount on more than 50 ...
TipRanks on MSN2d
iX Biopharma Unveils Growth Plans at AGMX Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd. recently held its Annual General Meeting where key ...
Cns Pharmaceuticals, Inc. ( (CNSP) ) has released its Q3 earnings. Here is a breakdown of the information Cns Pharmaceuticals, Inc. presented ...
The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
Leerink Partners analyst Mani Foroohar maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) on November 12 and set a ...
“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...
BP p.l.c.'s recent management changes and strategic moves, including the Travel Centers of ... when combined with an action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback